Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CELLSEED INC.

Home Clinical Trial Sponsors and OrganizationsCELLSEED INC.

CELLSEED INC.

2-5-10, AOMI, Koto-Ku, Tokyo, Japan

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

5

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 3

3

60.0%

Trial Status Distribution

Completed

2

40.0%

Recruiting

2

40.0%

Terminated

1

20.0%

Clinical Trials

Trials sponsored by this organization (5)

A Phase III Study of CLS2901C in Patients With Osteoarthritis of the Knee

Oct 202396 participants

A Study to Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial Esophageal Cancer in the Steroid Administration Risk Group

Feb 20211 participant

Human (Autologous) Oral Mucosal Cell Sheet Transplantation After ESD in Patients With Superficial Esophageal Cancer

Apr 201610 participants

A Phase III Study of CLS2901C in Patients with Osteoarthritis of the Knee

96 participants

A Study to Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial Esophageal Cancer in the steroid administration risk group (CLS2702-ESO-02)

17 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials5
Approvals
News

Back to Organizations